Carcinoma, Papillary

• 

  Subject Areas on Research

  • A Bedside Risk Calculator to Preoperatively Distinguish Follicular Thyroid Carcinoma from Follicular Variant of Papillary Thyroid Carcinoma. 
  • A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas. 
  • A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma. 
  • A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors. 
  • A pilot case-control study of gamma-radiation sensitivity and risk of papillary thyroid cancer. 
  • Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer. 
  • An exponential growth in incidence of thyroid cancer: trends and impact of CT imaging. 
  • An update on noninvasive follicular thyroid neoplasm with papillary-like nuclear features. 
  • An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC). 
  • Applying Criteria of Active Surveillance to Low-Risk Papillary Thyroid Cancer Over a Decade: How Many Surgeries and Complications Can Be Avoided? 
  • Association of BRCA1 functional single nucleotide polymorphisms with risk of differentiated thyroid carcinoma. 
  • BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. 
  • Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer. 
  • Central lymph node dissection in patients with papillary thyroid cancer: a population level analysis of 14,257 cases. 
  • Cervical lymph node metastasis and papillary thyroid carcinoma: does the compartment involved affect survival? Experience from the SEER database. 
  • Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas. 
  • Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profiles. 
  • Combined positron emission tomography - computed tomography improves specificity for thyroid carcinoma by identifying vocal cord activity after laryngeal nerve paralysis. 
  • Current Controversy of Radiographic Surveillance of Patients With Branch-duct IPMN and Pancreatic Cysts: Commentary on: Ductal Carcinoma Arising in a Largely Unchanged Presumed Branch Duct IPMN After 10 Years of Surveillance. 
  • Current Guidelines for Postoperative Treatment and Follow-Up of Well-Differentiated Thyroid Cancer. 
  • Cytologically low grade malignancies: an important interpretative pitfall responsible for false negative diagnoses in fine-needle aspiration of the breast. 
  • Defining Papillary Carcinoma of the Thyroid: A Short Review and Analysis. 
  • Delayed treatment of papillary thyroid carcinoma arising from struma ovarii in a patient with history of bilateral salpingo-oophorectomy: a case report. 
  • Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma. 
  • Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium. 
  • Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms. 
  • Effect of Tumor Size on Risk of Metastatic Disease and Survival for Thyroid Cancer: Implications for Biopsy Guidelines. 
  • Evaluation of cervical lymph nodes in head and neck cancer with CT and MRI: tips, traps, and a systematic approach. 
  • Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems. 
  • Exposure to flame retardant chemicals and occurrence and severity of papillary thyroid cancer: A case-control study. 
  • Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. 
  • Extrathyroidal Extension Is Associated with Compromised Survival in Patients with Thyroid Cancer. 
  • Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma. 
  • GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma. 
  • Gastrin-releasing peptide gene expression in developing, hyperplastic, and neoplastic human thyroid C-cells. 
  • Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. 
  • Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile. 
  • How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer. 
  • I-131, I-123, and F-18 FDG-PET imaging in a patient with diffuse sclerosing variant of papillary thyroid cancer. 
  • Imaging-guided core needle biopsy of papillary lesions of the breast. 
  • Immunocytochemistry for SOX-11 and TFE3 as diagnostic markers for solid pseudopapillary neoplasms of the pancreas in FNA biopsies. 
  • Immunoglobulin localization in benign and malignant lesions of the human mammary gland. 
  • Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. 
  • In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease. 
  • Incidental metastatic papillary thyroid carcinoma in microvascular reconstruction. 
  • Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. 
  • Iodine quantification to distinguish clear cell from papillary renal cell carcinoma at dual-energy multidetector CT: a multireader diagnostic performance study. 
  • Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer. 
  • LGR5 is associated with tumor aggressiveness in papillary thyroid cancer. 
  • Low-Grade Papillary Schneiderian Carcinoma of the Sinonasal Cavity and Temporal Bone. 
  • Lymphovascular invasion is associated with survival for papillary thyroid cancer. 
  • Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. 
  • Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid Carcinoma. 
  • Micropapillary thyroid carcinoma and concomitant ectopic thyroid tissue in the adrenal gland: metastasis or metaplasia? 
  • Modified radical mastectomy with immediate reconstruction for carcinoma of the breast. 
  • Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP). 
  • Molecular genetics and histopathologic features of adult distal nephron tumors. 
  • Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier. 
  • Obesity is associated with worse overall survival in women with low-grade papillary serous epithelial ovarian cancer. 
  • Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation. 
  • Outcomes in surgical stage I uterine papillary serous carcinoma. 
  • Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas. 
  • Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm. 
  • Papillary carcinoma of the breast: imaging findings. 
  • Patients Treated at Low-Volume Centers have Higher Rates of Incomplete Resection and Compromised Outcomes: Analysis of 31,129 Patients with Papillary Thyroid Cancer. 
  • Patterns of Initial Recurrence in Completely Resected Papillary Thyroid Carcinoma. 
  • Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misuse. 
  • Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram. 
  • Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer. 
  • Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid Cancer. 
  • Primary carcinoma of the upper urinary tract. Effect of primary and secondary therapy on survival. 
  • Primary thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: A case report and literature review. 
  • Progression of disease despite good endoscopic local control of upper tract urothelial carcinoma. 
  • Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts. 
  • Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes. 
  • Recurrence patterns of intraductal papillary mucinous neoplasms of the pancreas on enhanced computed tomography. 
  • Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. 
  • Revisiting overdiagnosis and fatality in thyroid cancer. 
  • Risk factors for ovarian cancers with and without microsatellite instability. 
  • Robotic thyroidectomy for cancer in the US: patterns of use and short-term outcomes. 
  • SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms. 
  • Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer. 
  • Sex is not an independent risk factor for survival in differentiated thyroid cancer. 
  • Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma. 
  • Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary/papillary thyroid carcinomas in 2 large, non-related families with the RET V804M proto-oncogene mutation. 
  • Solid pseudo-papillary tumors of the pancreas: current update. 
  • Sonographic Detection of Extracapsular Extension in Papillary Thyroid Cancer. 
  • Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes. 
  • Sternal metastasis as first presentation of a well-differentiated papillary thyroid carcinoma. 
  • Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. 
  • Suspicious ultrasound characteristics predict BRAF V600E-positive papillary thyroid carcinoma. 
  • The Flip Side of NIFTP: an Increase in Rates of Unfavorable Histologic Parameters in the Remainder of Papillary Thyroid Carcinomas. 
  • The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories. 
  • The Impact of Pathologically Positive Lymph Nodes in the Clinically Negative Neck: An Analysis of 39,301 Patients with Papillary Thyroid Cancer. 
  • The changing incidence of thyroid cancer. 
  • The changing landscape of papillary thyroid cancer: Epidemiology, management, and the implications for patients. 
  • The management of intraductal papillary mucinous neoplasms of the pancreas. 
  • The utility of thyroglobulin washout studies in predicting cervical lymph node metastases: One academic medical center's experience. 
  • Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapy. 
  • Thyroglossal duct cyst carcinoma: case report and review of the literature. 
  • Thyroid cancer in childhood: a retrospective review of childhood course. 
  • Thyroid neoplasia following irradiation for medulloblastoma: report of two cases. 
  • Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. 
  • Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients. 
  • Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease. 
  • Uncinate duct dilation in intraductal papillary mucinous neoplasms of the pancreas: a radiographic finding with potentially increased malignant potential. 
  • Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. 
  • What Is the Optimal Treatment of Papillary Thyroid Cancer? 
  • Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Hoang, Jenny K., Associate Professor of Radiology, Radiology, Neuroradiology